Integrated pan-cancer analysis of RNA binding protein HuR investigates its biomarker potential in prognosis, immunotherapy, and drug sensitivity
Fig 3
The diagnostic value of HuR across pan-cancers was accessed with ROC analysis and TMB analysis.
(A) The ROC curves of HuR across cancers were evaluated in BLCA, BRCA, CESC, COAD, ESCA, HNSC, KICH, LIHC, LUAD, LUSC, PCPG, PRAD, READ, SARC, STAD, and UCEC. AUC: area under curve. (B) Pearson correlation analysis between HuR and TMB across cancers was performed with scatter diagram. (C) Landscape of pearson correlation between HuR and TMB was displayed with radar plot. R, Pearson correlation coefficient. P, P-value of Pearson correlation. TMB, tumor mutation burden; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.